Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS

Title
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY
Volume 259, Issue 5, Pages 898-905
Publisher
Springer Nature
Online
2011-10-18
DOI
10.1007/s00415-011-6275-7

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search